Impact of local liver irradiation concurrent versus sequential with lenvatinib on pharmacokinetics and biodistribution

Tung Hu Tsai, Yu Jen Chen, Li Ying Wang, Chen Hsi Hsieh*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Concurrent and sequential regimens involving radiotherapy (RT) and lenvatinib were designed with off-target or stereotactic body radiation therapy (SBRT) doses in a freely moving rat model to evaluate the effect of RT on the pharmacokinetics (PK) of lenvatinib. Liver RT concurrent with lenvatinib decreased the area under the concentration–time curve of lenvatinib concentration (AUClenvatinib) by 51.1% with three fractions of 2 Gy (RT2Gy×3f’x, p = 0.03), and 48.9% with RT9Gy×3f’x (p = 0.03). The AUClenvatinib increased by 148.8% (p = 0.008) with RT2Gy×3f’x, and 68.9% (p = 0.009) with RT9Gy×3f’x in the sequential regimen compared to the concurrent regimen. There were no differences in the AUClenvatinib between RT2Gy×3f’x and RT9Gy×3f’x in the concurrent or sequential regimen. Both the RT2Gy×3f’x and RT9Gy×3f’x concurrent regimens markedly decreased the biodis-tribution of lenvatinib in the heart, liver, lung, spleen, and kidneys, which ranged from 31% to 100% for RT2Gy×3f’x, and 11% to 100% for RT9Gy×3f’x, compared to the sham regimen. The PK and biodistribution of lenvatinib can be modulated by simultaneous off-target irradiation and SBRT doses. The timing of lenvatinib administration with respect to RT, impacted the PK and biodistribution of the drug. Additionally, off-target and SBRT doses had a similar ability to modulate the effect of systemic therapy.

Original languageEnglish
Article number1598
Issue number7
StatePublished - 1 Apr 2021


  • Biodistribution
  • Hepatocellular carcinoma
  • Lenvatinib
  • Pharmacokinetics
  • Radiotherapy


Dive into the research topics of 'Impact of local liver irradiation concurrent versus sequential with lenvatinib on pharmacokinetics and biodistribution'. Together they form a unique fingerprint.

Cite this